Multivariate analysis for survival in adult AML patients who underwent HLA-identical sibling (MRD) HCT or 8/8 or 7/8 MUD HCT from 2002-2006 in the United States
| . | Death, RR (95 % CI) . | P . |
|---|---|---|
| 8/8 MUD vs MRD | 1.03 (0.90-1.17) | .62 |
| 7/8 MUD vs MRD | ||
| Early (≤ 6 mo after HCT) | 1.40 (1.15-1.70) | < .001 |
| Late (> 6 mo) | 0.88 (0.69-1.12) | .30 |
| 7/8 MUD vs 8/8 MUD | ||
| Early (≤ 6 mo after HCT) | 1.35 (1.13-1.62) | < .001 |
| Late (> 6 mo) | 0.85 (0.68-1.07) | .17 |
| . | Death, RR (95 % CI) . | P . |
|---|---|---|
| 8/8 MUD vs MRD | 1.03 (0.90-1.17) | .62 |
| 7/8 MUD vs MRD | ||
| Early (≤ 6 mo after HCT) | 1.40 (1.15-1.70) | < .001 |
| Late (> 6 mo) | 0.88 (0.69-1.12) | .30 |
| 7/8 MUD vs 8/8 MUD | ||
| Early (≤ 6 mo after HCT) | 1.35 (1.13-1.62) | < .001 |
| Late (> 6 mo) | 0.85 (0.68-1.07) | .17 |
Factors that were significant in the final model include recipient age, KPS, disease status at transplantation, and cytogenetic findings at diagnosis.